Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy
NCT00004149
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
arsenic trioxide
Sponsor
Albert Einstein College of Medicine
Collaborators
[object Object]